AcuCort confirms good progress in ISICORT® national application process
AcuCort AB (Spotlight Stock Market: ACUC) received the Second Round Assessment Report from the Swedish MPA as planned in July. Thanks to the ambitious work answering the authority’s questions in the previous round, the Second Round Assessment Report is less extensive and no major issues can be foreseenAcuCort received the Second Round Assessment Report from the Swedish Medical Products Agency (MPA), for the ISICORT® national approval process, as per the application timeline. Now having made an assessment of the remaining questions, with regulatory support and further evaluation by the